Axis-Shield, an in vitro diagnostics company, has renewed its Afinion US distribution contract with Abbott Laboratories and signed new agreements with Abbott's physician office laboratory partner PSS World Medical.
Subscribe to our email newsletter
These agreements have an initial term to 2011 and effectively extend and strengthen existing distribution arrangements, giving Abbott and PSS exclusive marketing rights to the Afinion system in the US.
Ian Gilham, CEO of Axis-Shield, said: “These agreements reflect the commitment of Abbott and PSS to Afinion and its proven superiority for measuring HbA1c at the point of care. We look forward to increasing sales of our flagship Afinion system in the important US market.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.